Concepedia

David Hinds

DH

Statistics

Publications

14

Citations

456

H-Index

12

Active since

2014

Affiliations

GlaxoSmithKline (United States)(Current)

BioMarin (United States)

Research Triangle Park Foundation

GlaxoSmithKline (United Kingdom)

Analysis Group (United States)

David Hinds is an author at GlaxoSmithKline (United States) specializing in pulmonary medicine, pulmonary disease, and health policy.

ORCID

Top concepts

Publications per year

2014–2023

14

Publications

14

Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort

Rachael L. DiSantostefano, David Hinds, Hoa Le et al. · Respiratory Medicine · 2016 · 72 citations

Physician perspectives on the burden and management of asthma in six countries: The Global Asthma Physician Survey (GAPS)

Kenneth R. Chapman, David Hinds, Peter Piazza et al. · BMC Pulmonary Medicine · 2017 · 67 citations · Full text

Risk of Pneumonia with Inhaled Corticosteroid versus Long-Acting Bronchodilator Regimens in Chronic Obstructive Pulmonary Disease: A New-User Cohort Study

Rachael L. DiSantostefano, Tim Sampson, Hoa Le et al. · PLoS ONE · 2014 · 58 citations · Full text

Identification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysis

David Hinds, Rachael L. DiSantostefano, Hoa Le et al. · BMJ Open · 2016 · 47 citations · Full text

Disease Burden of Patients with Asthma/COPD Overlap in a US Claims Database: Impact of ICD-9 Coding-based Definitions

Keele Wurst, Samantha St. Laurent, David Hinds et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2017 · 31 citations · Full text

, , +22

1–5 of 14